Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By

174 Results

  • Product not yet rated Includes a Live Web Event on 04/30/2024 at 11:00 AM (PDT)

    Content provided by Beckman Coulter (No CE credits offered)

    Webinar Description: 

    In this follow-up to the 2023 webinar, sponsored by Beckman Coulter, take a deeper dive into the CBC test results with a special focus on the white blood cells and differential. Uncover hidden gems and learn about clues pointing to sepsis recognition in order to provide the right care to the right patient at the right time. This sponsored webinar will focus on understanding novel components of the CBC with Diff and the Monocyte Distribution Width (MDW) marker for determining the severity of infection. 

    No CE credits are offered for this Sponsor Innovation Webinar.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Beckman Coulter for this Sponsor Innovation Webinar.

    image

    Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN

    Clinical Nurse Specialist/Consultant

    ADVANCING NURSING, LLC

    Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN, is a critical care clinical nurse specialist and consultant. She has published and lectured nationally and internationally on a variety of pulmonary, critical care, work culture, and sepsis topics, as well as on prevention of health care acquired injuries, including pressure injury and CAUTIs/CLALBSIs and other HAIs. She serves as a subject matter expert on these topics for the American Hospital Association and Michigan Hospital Association. From 1989 to 2003, she functioned in the role of Clinical Nurse Specialist for the Medical ICUs at Henry Ford Hospital in Detroit, Michigan. Currently her company, ADVANCING NURSING LLC, is focused on creating empowered work environments for healthcare practitioners through the acquisition of better skills, attainment of greater knowledge, and implementation of process improvement.

  • Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

    Description

    Sepsis Alliance’s 2023 publication, The Healthcare C-Suite AMR Market Report found that only 26% of U.S. healthcare leaders grade themselves an ‘A’ on their hospital or health system’s antimicrobial resistance (AMR) efforts. The Sepsis Alliance AMR Conference aims to provide the tools and knowledge to improve these AMR efforts.

    Sepsis and the emergence of antimicrobial resistance (AMR) are intricately intertwined and pose significant challenges. Primary reliance on broad-spectrum antimicrobials is often the initial approach in sepsis treatment, yet, curbing unnecessary antimicrobial use is imperative in combating the escalating threat of AMR.

    As AMR intensifies, the likelihood of infections progressing to sepsis increases, rendering sepsis cases progressively more resistant to treatment and consequently subjecting patients to adverse outcomes such as amputations and fatalities. Effectively managing this intricate clinical interplay, addressing the global AMR threat, and enhancing future outcomes necessitate collaborative efforts across sectors, ongoing innovation, and educational initiatives.

    Opportunities for AMR education for clinicians, caregivers, patients, and the public are viewed by 77% of healthcare executives as necessary for combating AMR. Participation in the Sepsis Alliance AMR Conference offers a unique opportunity for attendees to explore innovative ideas, gain inspiration, and learn about practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.

    Topics covered will include:

    • A One Health approach to combating AMR;
    • Maternal and pediatric AMR;
    • AMR in ambulatory and outpatient settings;
    • The role of Sepsis Teams in AMS.

    Learning Objectives:

    At the conclusion of this event, learners will be able to:

    • Explain the intricate link between sepsis and antimicrobial resistance;
    • Identify tools and resources to champion responsible antimicrobial prescribing practices;
    • Describe the pivotal role of healthcare executives and leadership in prioritizing, endorsing, and advancing stewardship efforts addressing antimicrobial resistance and sepsis;
    • Restate methods for leadership to actively pursue inventive approaches that engage healthcare providers in initiatives aimed at tackling antimicrobial resistance and enhancing sepsis management.

    FREE Nursing CE Credits Offered! 

    Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.

    Conference Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:

    image       image         image

    Agenda

    April 10, 2024

    Time (ET)Session TitlePresenter
    10:00-10:15Opening Remarks
    10:20-10:50Keynote
    10:55-11:25One Health in Action: Minnesota’s Collaborative Approach to Antibiotic Stewardship (CE Session)Kristen Clark, DVM, MPH, DACVPM, CCRT
    Director, Minnesota One Health Antibiotic Stewardship Collaborative, Minnesota Department of Health
    11:30-12:00Sponsor Track 1: Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and SepsisJames Graham
    Managing Director & Chief Executive Officer, Recce Pharmaceuticals
    12:00-12:15Break
    12:15-12:45Details Coming Soon
    12:50-1:20Details Coming Soon

    1:25-1:55Sponsor Track 1: bioMérieux Sponsored Session (Details Coming Soon)

    1:55-2:10Break

    2:10-2:40The Epidemiology of Antimicrobial Resistant Bacteria in the Pediatric Population (CE Session) 
    Rachel Medernach, MD, MSCI
    Assistant Professor, Rush University Medical Center
    2:45-3:15
    Details Coming Soon
    3:20-3:35
    Sponsor Session (Details Coming Soon)

    3:40-3:55Sponsor Session (Details Coming Soon)

    3:55-4:25Antimicrobial Stewardship: Important to All (CE Session)Alyssa R. Letourneau, MD, MPH, FIDSA
    Assistant Professor of Medicine, Harvard Medical School
    4:35-4:50Closing Remarks

    April 11, 2024

    Time (ET)Session TitlePresenter
    10:00-10:15Welcome and Opening Remarks
    10:20-10:50Keynote
    11:55-11:25Details Coming Soon
    11:30-12:00Sponsor Track 1: BD Sponsored Session: The Vital Role of Blood Culture Quality & Phenotypic ID/AST Results on Sepsis Patient Outcomes
    Masashi Waga
    Technical Director, Clinical Microbiology and Senior Manager, Clinical Microbiology
    12:00 - 12:15Break
    12:15-12:45
    Antibiotic Resistance and Cancer: Challenges and Potential Solutions (CE Session)
    David Greenberg, MD
    Professor of Infectious Diseases and Microbiology, UT Southwestern
    12:50-1:20Details Coming Soon
    1:25-1:40Sponsor Session (Details Coming Soon)
    1:45-2:00Sponsor Session (Details Coming Soon)
    2:00-2:15Break
    2:15-2:45Decolonization to Prevent Serious Infections and Antibiotic Resistant Pathogens: Extending the Benefit to Long-Term Care (CE Session)Susan Huang, MD MPH
    Chancellor’s Professor, University of California Irvine School of Medicine
    2:50-3:20Candida auris: A Global Emerging Multidrug Resistant Pathogen (CE Session)Mahmoud A. Ghannoum, PhD, MBA, FIDSA, FAAM
    Professor, Case Western Reserve University and University Hospitals Cleveland Medical Center
    3:25-3:55Sponsor Session (Details Coming Soon)
    4:00-4:30The Need for and Approaches to Outpatient Antibiotic Stewardship (CE Session)Rachel Zetts, MPH
    Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
    4:35-4:50Closing Remarks
  • Product not yet rated Includes a Live Web Event on 03/27/2024 at 11:00 AM (PDT)

    Content provided by Baxter (No CE credits offered)

    Webinar Description: 

    In this sponsored webinar, Morgan Swearingin, MSN-Ed, RN, CCRN, will discuss the process and experience of creating nurse-driven protocols for SEP-1 interventions and fluid management from the perspective of a bedside nurse and clinical educator. Morgan will explore navigating potential barriers to implementing a successful program. Then, she will conversely highlight breakthroughs and improvements in sepsis care and nursing competence at her institution after implementing nurse-driven protocols and targeted education.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Baxter for this sponsored webinar.

    image


    Morgan Swearingin, MSN-Ed, RN, CCRN

    Critical Care Clinical Education Specialist

    North Kansas City Hospital

    Morgan Swearingin, MSN-Ed, RN, CCRN, is a critical care clinical education specialist at North Kansas City Hospital. Morgan has served in this role for the past 3.5 years, with close to 15 years total of experience in acute care nursing. She graduated in 2009 with an Associate of Science in Nursing (ASN) degree from Hannibal-LaGrange University, and then in 2014 she achieved a Master of Science in Nursing (MSN) degree with an emphasis in Nursing Education from Walden University. Morgan is certified as a critical care registered nurse (CCRN) through the American Association of Critical Care Nurses (AACN), and is notably involved in her local AACN chapter, serving currently as the chapter president of the board of directors. Morgan is passionate about empowering direct care nurses through equipping them with knowledge, competence, and awareness around sepsis identification and management.

  • Includes a Live Web Event on 03/21/2024 at 11:00 AM (PDT)

    In the second part of this 2-part series focusing on sepsis education and prevention for school-based healthcare professionals, we'll explore the crucial role of school-based healthcare professionals in recognizing the high risk for sepsis in children, including knowing the key signs and symptoms requiring escalation in care to either a PCP or emergency departments.

    Description: 

    Date: March 21, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    Sepsis affects more than 50 million people worldwide each year, and almost half are children. Although sepsis is the major cause of death within hospitals, up to 87% of sepsis cases originate in the community before patients are admitted. Any number of infections can trigger sepsis in school-aged children. In the second part of this 2-part series focusing on sepsis education and prevention for school-based healthcare professionals, we'll explore the crucial role of school-based healthcare professionals in recognizing the high risk for sepsis in children, including knowing the key signs and symptoms requiring escalation in care to either a PCP or emergency departments. We’ll also cover how to support children who have experienced sepsis. Attendees will learn practical strategies to identify and address time-sensitive clinical deterioration from sepsis, as well as how to best support the lingering effects of post-sepsis syndrome in students, to avoid unnecessary returns to the hospital and potential frequent readmissions.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Distinguish which children may be at highest risk for sepsis and summarize key signs and symptoms indicating clinical deterioration and need for timely escalation in care;
    • List potential lasting affects pediatric sepsis survivors may face post-sepsis;
    • Describe strategies for supporting students and their families during and post-sepsis;
    • Identify educational opportunities for educating students and their families on the importance of early sepsis recognition and treatment.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporter:

    This educational resource is supported by a grant from the Del E. Webb Foundation.

    image

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Fran Balamuth, MD, PhD, MSCE

    Associate Professor of Pediatrics

    University of Pennsylvania

    Fran Balamuth MD, PhD, MSCE, is an Associate Professor of Pediatrics at the University of Pennsylvania and an attending physician in the emergency department at the Children’s Hospital of Philadelphia (CHOP).  Dr. Balamuth’s research interests focus on pediatric sepsis recognition using both epidemiologic and translational approaches, for which she has received both NIH and foundational funding. She is the co-primary investigator of the PROMPT BOLUS trial, a multinational pragmatic trial that compares saline vs. balanced fluids in pediatric sepsis and will be the largest acute care pediatric trial in history. In addition, she co-leads the CHOP Pediatric Sepsis Program, which supports and promotes local clinical, research, educational, and quality improvement initiatives around sepsis. She is an internationally recognized sepsis leader and has been invited to serve on the national steering committee for the Improving Pediatric Sepsis Outcomes quality collaborative through the U.S. Children’s Hospital Association, and three international task forces focused on defining pediatric sepsis through the U.S. Centers for Disease Control and Prevention (CDC), the Surviving Sepsis Campaign, and the Society of Critical Care Medicine.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Includes a Live Web Event on 03/18/2024 at 11:00 AM (PDT)

    Through a comprehensive analysis of the epidemiology of pediatric sepsis, attendees will gain valuable insights into the prevalence, risk factors, and clinical implications of this life-threatening condition among children.

    Description: 

    Date: March 18, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify risk factors of pediatric sepsis;  
    • List ways school-based healthcare professionals can support pediatric sepsis prevention;  
    • Describe how school-based healthcare professionals can educate families and students about infection and sepsis prevention, and the importance of vaccinations.  

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporter:

    This educational resource is supported by a grant from the Del E. Webb Foundation.

    image

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Joseph Carcillo, MD

    Professor of Critical Care Medicine and Pediatrics

    University of Pittsburgh, Department of Critical Care Medicine

    Joseph Carcillo, MD, specializes in pediatric critical care medicine and pediatrics, and is certified by the American Board of Pediatrics. He is affiliated with UPMC Horizon, UPMC Mercy, UPMC Children's Hospital of Pittsburgh, UPMC Altoona, and UPMC Northwest. He completed his medical degree at George Washington University Medical Center, along with a residency and fellowship at Children's National Medical Center. He was previously Taskforce Chair of the ACCM Guidelines for Hemodynamic Support of Newborn and Pediatric Septic Shock, and a member of the Centers for Disease Control and Prevention (CDC) Taskforce for Definitions of Pediatric Sepsis.  

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Includes a Live Web Event on 02/29/2024 at 11:00 AM (PST)

    Live webinar in a "train the trainer" style format about home care responsibilities, infection management, and approaching to maintaining a safe care environment.

    Description: 

    Date: February 29, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    Patients and caregivers play a pivotal role in infection prevention in home care settings. Infusions administered in a home-based setting receive less frequent monitoring by a healthcare professional than those administered in a hospital, putting patients at an increased risk of sepsis and other complications due to infection. 
     
    In this comprehensive presentation, the presenter will discuss the intricacies of home care, focusing on the distinct roles of patients, caregivers, and healthcare workers in home care. The various types of infections that may arise in a home care setting will be explored, as well as proactive measures to ensure a safe and conducive home care environment. Additionally, the session will provide a review of patient education tools, patient video, and “train the trainer” video available to participants for use and education of their staff, patients, and caregivers. Participants will obtain a comprehensive understanding of home care responsibilities, infection management, and the nuanced approach required to maintain a safe and effective care environment.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify the responsibilities of patients, caregivers, and healthcare workers in home care;
    • Describe types of infections that may occur in home care;
    • Explain the role of patients and caregivers in infection prevention in home care;
    • List warning signs of sepsis in home care;
    • Describe how to balance prevention of antibiotic resistance with management of sepsis in home care.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Supporters:

    Funding for this program was provided in part by an independent educational grant from Pfizer, Inc.

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Sara Keller, MD, MPH, MSPH

    Associate Professor, Division of Infectious Diseases

    Johns Hopkins University School of Medicine

    Sara Keller, MD, MPH, MSPH, is an Associate Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She has joint appointments as Associate Faculty in the Armstrong Institute for Patient Safety, and in the Health Policy and Management Department of the Johns Hopkins University Bloomberg School of Public Health. Her research focuses on expanding healthcare epidemiology and antibiotic stewardship to the outpatient setting, using quantitative and qualitative methods, and applying a human factors engineering framework. She has particularly been recognized for her expertise in improving the quality of care of patients on outpatient parenteral antimicrobial therapy (OPAT), central line-associated bloodstream surveillance and prevention in home infusion therapy, and implementing antibiotic stewardship programs in ambulatory clinics. Her research is funded by the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, and the National Institute on Aging.

    Dr. Keller graduated from Duke University School of Medicine in 2007 and received a Public Health degree with a specialization in epidemiology from the University of North Carolina at Chapel Hill in 2006. She completed her internship and residency in internal medicine at Johns Hopkins University School of Medicine in 2010, then transitioned to the University of Pennsylvania for her infectious diseases training in 2013. She completed a two-year simultaneous fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety, and received a Masters in Health Services Research.

    She also developed and serves as Director of the Patient Safety and Quality Improvement Pathway for Johns Hopkins University School of Medicine Osler Medical Residency Program and directs the Johns Hopkins OPAT Program.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Content provided by Immunexpress (No CE credits offered)

    Webinar Description: 

    In this sponsored webinar, Roy Davis, MD, PhD, MHA, Chief Medical Officer of Immunexpress, will introduce SeptiCyte RAPID, a one-hour, FDA-cleared test to differentiate sepsis from non-infectious systemic inflammation,. Dr. Davis will also share clinical validation data and describe its impact in sepsis bundle compliance. Russell Miller, MD, MPH, FCCM, will then explain the clinical value of SeptiCyte RAPID, especially when there is diagnostic uncertainty in patients suspected of sepsis, and why this led to its adoption at his hospital.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Immunexpress for this sponsored webinar.

    image


    Roy F. Davis MD, PhD, MHA

    Chief Medical Officer

    Immunexpress

    Roy F. Davis MD, PhD, MHA, has 30 years’ experience in clinical medicine (neonatal and pediatric critical care) and hospital administration. He was Clinical Assistant Professor in the Department of Pediatrics at the University of Washington and has served as a consultant in health care standards and quality of care delivered. He implemented MEWS and sepsis surveillance algorithms while serving as Chief Medical Officer at Providence Alaska, winning a national Microsoft Healthcare Innovation Award. At Immunexpress, he has been involved in the development and clinical validation of SeptiCyte RAPID and its role of in the diagnosis of sepsis.

    Russell R. Miller, MD, MPH, FCCM

    Medical Director of Critical Care

    FirstHealth of the Carolinas

    Russell R. Miller, MD, MPH, FCCM, is an Intensivist and Medical Director of Critical Care at FirstHealth of the Carolinas in Pinehurst, North Carolina. Previously, he was Chair of the Critical Care Development Team for Intermountain Healthcare and Director of the Respiratory ICU at Intermountain Medical Center. He completed his undergraduate training at Duke University, medical and residency training in the southeast United States, and then a Pulmonary and Critical Care Medicine fellowship at Vanderbilt University. His academic interests have included sepsis, pneumonia and associated lung injury, sedation and delirium in the ICU, and ICU mobility.

  • Learn about a state-wide quality collaborative with resources provided by HMS helps to drive quality improvement and education at a variety of sites across Michigan.

    Description: 

    The Michigan Hospital Medicine Safety Consortium (HMS) is a data-driven collaborative supported by Blue Cross and Blue Shield of Michigan. HMS provides the infrastructure needed to facilitate data collection and information sharing to support Michigan hospitals in improving the safety and quality of care for hospitalized medical patients. In 2021, HMS launched a sepsis initiative among 12 volunteer pilot hospitals. In 2022, the sepsis initiative was launched among the remaining 57 HMS hospitals. The HMS sepsis initiative assesses the care of patients meeting surveillance criteria for sepsis with the goal of improving patient experience and outcomes across the continuum of care – from early identification and management to post-discharge care coordination and 90-day outcomes.

    The presentation will begin with Dr. Prescott introducing participants to HMS and discussing why HMS and Blue Cross and Blue Shield of Michigan identified sepsis as a priority for Michigan hospitals. HMS data provided to participating sites will be reviewed with examples of how sites are utilizing the data, tools, and resources provided by HMS to drive quality improvement and education at their sites. Following Dr. Prescott’s presentation will be a panel session that engages HMS physicians, BCBSM leadership, a Sepsis Quality Improvement Consultant, and a physician representative from an HMS participating site.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Summarize the processes and infrastructure provided by HMS Sepsis to facilitate quality improvement and collaborations across Michigan hospitals;
    • Restate the wide differences in sepsis practice across Michigan sites that result in variance in success rates for performance metrics;   
    • Identify the various interventions sites have taken to implement quality improvement work for management of patient with sepsis;
    • Summarize how various members of quality collaboratives work together to create mutually beneficial relationships.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporter: 

    Sepsis Alliance gratefully acknowledges the support provided by the Sepsis Alliance Institute Sponsor.

    image

    Hallie Prescott, MD, MSc

    Associate Professor

    University of Michigan

    Dr. Hallie Prescott is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She is an expert in long-term outcomes and recovery after sepsis. Her research program has been funded by AHRQ, NIH, and Department of Veterans Affairs. She is a vice-chair of the Surviving Sepsis Campaign guidelines, council member of the International Sepsis Forum, and physician-lead for a BlueCross/Blue Shield of Michigan sepsis quality improvement consortium of 50 Michigan hospitals.

    Pat Posa RN, BSN, MSA, CCRN-K, FAAN

    Quality and Patient Safety Program Manager

    UH/CVC, Michigan Medicine

    Pat Posa is the Quality and Patient Safety Program Manager for UH/CVC at Michigan Medicine. In this role, she is responsible for development, measurement and sustainability of the UH/CVC segment quality and patient safety program. Most recently, Pat was a Quality Excellence Leader for St. Joseph Mercy Health System in Southeastern Michigan, leading initiatives to reduce hospital-acquired conditions, improve patient outcomes for critically ill patients, and reduce readmissions. She also works as the Population Health Clinical Integration Leader. In this role she has implemented a risk prediction tool and associated interventions within the hospital and post-acute settings. She also works as a Quality Excellence Leader for St. Joseph Mercy Hospital. She has held various roles in healthcare in the hospital, ambulatory setting, and health plan over her 40 years in practice, including manager of inpatient critical care units, Director of Nursing, and administrator of an outpatient multispecialty/primary care clinic. Pat has been involved in many quality and patient safety programs such as hospital- and system-wide sepsis management programs and a statewide Keystone ICU patient safety initiative. She has served on the faculty for multiple state and national clinical collaboratives including the Surviving Sepsis Campaign Phase IV Collaborative, the national project on Comprehensive Unit Safety Program (CUSP) for Mechanically Ventilated Patients, and Society of Critical Care Medicine’s ICU Liberation Collaborative. Through Pat's leadership, St. Joseph Mercy Hospital was awarded the HHS / Critical Care Societies Outstanding Leadership in Eliminating CLABSI and VAP in 2011. She was inducted as a fellow into the American Academy of Nursing in 2013. Pat was also awarded the Michigan Hospital Association Quality and Patient Safety Leadership Award in 2017. Pat has published many articles in both clinical and quality journals. She lectures and consults extensively nationally on sepsis, critical care, patient safety, and quality topics. Pat received a Bachelor in Nursing from Wayne State University in Detroit, Michigan and her Masters of Science in Administration from Central Michigan University in Mt. Pleasant, Michigan.

    Scott Flanders, MD

    Chief Clinical Strategy Officer

    Michigan Medicine

    Scott Flanders, MD, Professor of Internal Medicine, serves as Chief Clinical Strategy Officer for Michigan Medicine, Vice Chair of External Relations in the Department of Internal Medicine, and is a hospitalist in the Division of Hospital Medicine. Dr. Flanders was a founding member of the Board of Directors of the Society of Hospital Medicine (SHM) and is a Past President of SHM. He received his Medical Degree from the University of Chicago Pritzker School of Medicine and completed his residency and chief residency at the University of California, San Francisco.

    Megan Cahill, DO, MBA

    Division Chief of Medicine

    Henry Ford Macomb Hospital

    Megan Cahill, DO, MBA, is a distinguished healthcare leader and the Division Chief of Medicine at Henry Ford Macomb Hospital, leading over 750 physicians and Advanced Practice Providers across 20 medicine specialties. With a servant leadership style, she excels in navigating complex decisions, fostering team collaboration, and adapting to change. As an Emergency Medicine physician, Dr. Cahill is well-versed in sepsis management and began her leadership journey overseeing the Sepsis Steering Committee as the Sepsis Improvement Physician Champion. This passion for enhancing clinical management of sepsis and improving patients’ lives sparked further quality improvement work in antimicrobial stewardship, diagnostic stewardship, hospital-acquired infections, and vascular access devices. Recognized for leadership in education, patient safety, and professional advocacy, Dr. Cahill's multifaceted expertise serves her larger vision for continuous advancements in healthcare nationwide.

    Amy McKenzie, MD, MBA

    Vice President, Clinical Partnerships and Associate CMO

    Blue Cross Blue Shield of Michigan

    Amy McKenzie, MD, MBA is a board-certified family medicine physician with 13 years of experience in private practice and over ten years of experience in healthcare administration and clinical leadership. Dr. McKenzie joined Blue Cross Blue Shield of Michigan in 2013 as a physician consultant supporting Quality Management and Accreditation and is now the Associate Chief Medical Officer and Vice President leading Clinical Partnerships. Her team is responsible for providing clinical leadership for provider value-based programs and risk contracting and helps to enable and support the network through education, communication, and partnering on practice transformation efforts. She also leads the Behavioral Health Strategy and Planning team responsible for development and implementation of the BH strategy. Dr. McKenzie graduated from Northeast Ohio Medical University and completed her residency at Ascension Providence Hospital in Southfield, Michigan. In 2017, she received her MBA with a focus in medical management from the University of Massachusetts Amherst. She is currently serving as Vice Chair on the State of Michigan Certificate of Need Commission and is a past president on the Family Medicine Foundation of Michigan.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.8 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.5 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Recorded On: 12/19/2023

    Content provided by InflaRX (No CE credits offered)

    Webinar Description: 

    This sponsored webinar will provide an overview of the Complement System and C5a Activation, the potential role of C5a in COVID-19 disease progression, and a review of the clinical data for a product recently FDA-authorized for emergency use in critically ill adult patients hospitalized with COVID-19.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by InflaRX for this sponsored webinar.

    Niels Riedemann, MD, PhD

    Chief Executive Officer and Founder

    InflaRX

    Niels Riedemann, MD, PhD, is a co-founder and CEO of InflaRx. He has over 15 years of experience in biotech and 23 years of experience in complement immunology research, with more than 60 peer-reviewed scientific publications in highly ranked journals and several national and international accolades for his research and work. From 2009 to 2015, he served as Vice Director of Intensive Care Medicine at Friedrich Schiller University in Jena, Germany, where he led a 50-bed academic ICU unit. He received his medical training from Albert Ludwig University and Stanford University, worked as postdoctoral research fellow at the University of Michigan, and received his PhD. from Hannover Medical School. He is board certified general surgeon and intensive care physician. Dr. Riedemann serves as Co-Chair of the Health Politics working group of Bio-Deutschland and as a member of the board of trustees for the German Sepsis Foundation.

  • Recorded On: 12/13/2023

    This live virtual event, scheduled for December 14, 2023, will cover critical topics related to HAIs, offering attendees the latest clinical knowledge and updated recommendations for timely infection prevention and treatment

    Description: 

    Date: December 14, 2023

    Time: 12:00 - 3:30 pm ET / 9:00 am - 12:30 pm PT

    Healthcare-associated infections (HAIs) are the most common complication associated with hospital care and continue to be a significant concern for critical care professionals. Centers for Disease Control and Prevention (CDC) reports that one in every 31 hospital patients acquires at least one HAI each day, costing billions for healthcare organizations. The potential for HAIs to lead to sepsis further emphasizes the need for HAI prevention measures, which also serve as sepsis prevention strategies.

    It is imperative for healthcare professionals to direct their focus towards identifying and capitalizing on opportunities for improving performance and outcomes across various departments and specialties related to HAIs and the prevention of infections that can lead to sepsis.

    To address this pressing issue, Sepsis Alliance is hosting the 2023 Sepsis Alliance Symposium: Healthcare-Associated Infection. This live virtual event, scheduled for December 14, 2023, will cover critical topics related to HAIs, offering attendees the latest clinical knowledge and updated recommendations for timely infection prevention and treatment. The aim of this half-day event is to establish the importance of HAI mitigation within clinical practices and enhance the overall clinical outcomes for patients affected by HAIs and sepsis.

    Topics covered will include: 

    • Healthcare-associated infection prevention priorities (CAUTIs, CLABSIs, VAEs, CDIFF, SSIs);
    • The Impact of MDROs including Candida Auris on HAIs;  Skin and Skin Structure Infections (SSIs, Cellulitis, and HAPIs);
    • HAI risks and considerations in immunocompromised patients. 

     This event is FREE for registrants and will offer CE contact hours for nurses.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Demonstrate increased knowledge relating to maintaining a compliant and effective infection prevention and control program in the healthcare setting;
    • Describe examples of infection prevention and control evidence-based best practices and recommendations;
    • Propose innovative approaches, protocols, tools and documentation for limiting healthcare-associated infections.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Symposium Supporters:

    This activity is supported through an Independent Medical Education grant from Merck & Co. Inc.

    Sepsis Alliance gratefully acknowledges the support provided for this event by Seres Therapeutics.

    image

    Cindy Hou DO, MA, MBA, FACOI, FACP, FIDSA (Moderator)

    Infection Control Officer

    Jefferson Health, New Jersey

    Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, is the Infection Control Officer and Medical Director of Research for Jefferson Health - New Jersey (JNJ) and an infectious diseases specialist. She is dually board certified in internal medicine and infectious diseases. Dr. Hou has expertise in sepsis, antibiotic stewardship, and infection control. Dr. Hou is the Chief Medical Officer of  Sepsis Alliance and a member of its board of directors; she is also a medical advisor for the Sepsis Innovation Collaborative. Dr. Hou earned an M.B.A. and M.A. from Boston University, a D.O. from the University of New England College of Osteopathic Medicine, and a BS from Yale University. She has a certification in Infection Prevention and Control (CIC), is a Certified Professional in Healthcare Quality (CPHQ), and a Certified Professional in Patient Safety (CPPS). Dr. Hou is a fellow for the American College of Osteopathic Internists (ACOI), American College of Physicians (ACP) and the Infectious Diseases Society of America (IDSA). 

    No relevant financial relationships to disclose.

    J. Hudson Garrett Jr., Ph.D., MPH, MBA, CPPS, FACHE, FSHEA, FNAP, FIDSA

    Adjunct Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine

    University of Louisville School of Medicine

    John Hudson Garrett Jr., Ph.D., MPH, MBA, CPPS, FACHE, FSHEA, FNAP, FIDSA is a driven, results-oriented, and collaborative healthcare and medical executive with a proven track record of growing clinical and medical affairs strategies across a broad variety of targets including both inpatient and outpatient healthcare settings, as well as community settings. Dr. Garrett has a passion for positively impacting patient safety through meaningful collaboration with patients, regulators, accreditation bodies, healthcare professionals, clinical organizations, industry partners, and integrated healthcare delivery networks. Dr. Garrett’s specific focus has been on the prevention of healthcare-associated and community-associated infection prevention and control, and he believes in advancing global evidence-based practices to reduce healthcare-associated infections, improve patient satisfaction and occupational safety, reduce costs, and improve overall healthcare outcomes.

    Charles Holland

    President and Chief Executive Officer

    St. Bernard Hospital

    Charles Holland is President and Chief Executive Officer of St. Bernard Hospital, a safety-net community hospital that has served the Englewood community and Chicago’s South Side for nearly 120 years. He joined the hospital in 1998, assuming his current leadership position on January 1, 2013. He is a member of the hospital’s Board of Trustees.

    Mr. Holland has been instrumental in advancing the stature of the hospital as a community leader. His focus is on programs to keep people well and help prevent disease. In 2016, the hospital opened a 70,000 square foot state of the art Ambulatory Care Center to offer comprehensive outpatient services. Also, he led the work on the hospital’s affordable housing project, establishment of the St. Bernard Hospital Dental Center and the Pediatric Mobile Health Unit program, which has delivered 20 years of service. 

    Under Mr. Holland’s leadership, the hospital significantly and swiftly improved its patient safety ratings, and it has attracted critical donations of improved technology to advance patient care. An unwavering advocate for health equity, Mr. Holland is president of the board of the Center for Better Aging, and he is also a board member of the South Side Healthy Community Organization.   

    Catherine Liu, MD

    Professor, Vaccine and Infectious Diseases Division

    Fred Hutchinson Cancer Center

    Catherine Liu, MD is an infectious diseases physician and professor in the Vaccine and Infectious Diseases Division at Fred Hutchinson Cancer Center (FHCC) and in the Division of Allergy and Infectious Diseases at University of Washington. She serves as the Director of the Antimicrobial Stewardship and Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs and Associate Director of Infection Prevention at FHCC. Her clinical and research interests focus on the implementation and evaluation of strategies to optimize antimicrobial use and infectious disease management in immunocompromised hosts with a focus on patients with cancer and hematopoietic cell transplant recipients.

    Melissa Miller, MD, MS, FCCM

    Medical Officer, Division of Healthcare-Associated Infections in the Center for Quality Improvement and Patient Safety

    Agency for Healthcare Research and Quality (AHRQ)

    Melissa Miller, MD, MS, FCCM, serves as Medical Officer with the Division of Healthcare-Associated Infections in the Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality (AHRQ). Dr. Miller is the Project Officer for the AHRQ Safety Program for MRSA Prevention. She was previously the Project Officer of the AHRQ Safety Program for Improving Antibiotic Use, which promoted antibiotic stewardship activities in multiple healthcare settings, and for the AHRQ Safety Program for ICUs: Preventing CLABSI and CAUTI. She represents AHRQ on the Presidential Advisory Committee on Combating Antibiotic-Resistant Bacteria (PACCARB) and as an ex-officio member of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC). She has training in internal medicine, infectious diseases, pulmonary medicine, and critical care medicine, and has a background as a critical care nurse. Prior to joining AHRQ, she held the position of Assistant Professor at the University of Michigan and Medical Director of the Medical Intensive Care Unit at the Ann Arbor VA Medical Center, and conducted research on the implementation of evidence-based multidisciplinary ICU interventions.    

    Michael Richardson, MHSc, BSN, RN, CPPS, CPHRM

    Chief Quality and Patient Safety Officer

    St. Bernard Hospital

    Michael Richardson, MHSc, BSN, RN, CPPS, CPHRM, is the Chief Quality and Patient Safety Officer at St. Bernard Hospital. Michael has been a Registered Nurse for over 30 years with a diverse background in the nursing profession. He obtained his master's degree in health science at Nova Southeastern University. He moved into risk management and patient safety approximately 15 years ago and has held several director roles for large health systems in South Florida.

    Michael moved to Chicago in the summer of 2021 and joined St. Bernard Hospital as the Chief Quality and Patient Safety Officer, where he has been instrumental in driving the safety culture at the hospital and improving the overall quality and safety of care. 

    With his leadership and patient safety background, he spearheaded the efforts to move St. Bernard from an ‘F’ grade to an ‘A’ grade within two years. Michael teaches patient safety principles to medical students at Rosalind Franklin University of Medicine and Science and is a board member of the Midwest Alliance for Patient Safety (MAPS) PSO.

    Nasia Safdar, MD, Ph.D

    Professor in Division of Infectious Disease

    University of Wisconsin School of Medicine and Public Health

    Nasia Safdar, MD, Ph.D,is a professor in the Division of Infectious Disease within the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, where she is s also Associate Dean for Clinical Trials and Research Director of the Wisconsin Medicine Institute for Clinical Trials. Dr. Safdar is also Faculty Director of Investigator-Initiated and Multisite Research, Institute for Clinical and Translational Research. Dr. Safdar serves as the Associate Chief of Staff for Research at the William S. Middleton Veterans Hospital and as the Medical Director of Infection Control at UW Health. Her research, which has been funded by VA, AHRQ, PCORI, and NIH, aims to reduce and prevent healthcare-associated infections by identifying, testing, and implementing novel interventions.

    Because of her work and research in this area, in 2017, Dr. Safdar received a President’s Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government on outstanding scientists and engineers beginning their independent careers. In 2018, she received the NIH Director’s New Innovator Award. In 2019, she received the Oswald Avery Award for Early Achievement which honors ISDA fellows aged 45 or younger for overall outstanding achievements in infectious disease. In 2021, Dr. Safdar became an invited fellow of the Alpha Omega Alpha Honor Medical Society.

    Frank A. Scannapieco, DMD, PhD

    Chair and SUNY Distinguished Professor of Oral Biology, Associate Dean for Faculty and Professional Development

    University at Buffalo School of Dental Medicine

    Frank Scannapieco, D.M.D., Ph.D. is a State University of New York (SUNY) Distinguished Professor of Oral Biology and has an international reputation in oral biology. His research interests have included studies of basic dental plaque (biofilm) formation mechanisms and implications for health and disease. His laboratory has studied the interaction between salivary proteins and bacteria, and how these influence oral biofilms. He is also a pioneer in studies connecting oral and systemic diseases such as pneumonia, COPD, diabetes, and cancer.

    A member of the University at Buffalo faculty since 1991. Dr Scannapieco served as the Chair of the Department of Oral Biology from 2004 to 2022. Over his career, he has mentored numerous junior faculty, postdoctoral fellows, and graduate, dental, and college students. He was awarded several research grants over his career, edited several books and journal supplements, and has published over 170 peer-reviewed articles and book chapters.

    A fellow of the American Association of Dental Research, Scannapieco has received several awards, including the SUNY Chancellor’s Award for Excellence in Scholarship and Creative Activities, Distinguished Scientist Award in Oral Biology from the International Association for Dental Research, the William J. Gies Award for Achievement from the American Dental Education Association, and the Irwin D. Mandel Distinguished Mentoring Award, from the American Association for Dental Research.

    He received a bachelor’s degree in biology and doctorate in dental medicine from the University of Connecticut, a master’s degree in biology from Northeastern University, and a PhD in oral biology and certificate in periodontics from the University at Buffalo.

    Agenda

    December 14, 2023

    Time (ET)Session TitlePresenter
    12:00-12:05Welcome and Opening RemarksCindy Hou DO, MA, MBA, FACOI, FACP, FIDSA
    Jefferson Health - East Region
    12:05-12:35Using Leapfrog’s Hospital Survey as a Safety Roadmap to Improve Hand Hygiene and Reduce HAIs  Charles Holland 
    St. Bernard Hospital  
    Michael Richardson, MHSc, BSN, RN, CPPS, CPHRM    
    St. Bernard Hospital 
    12:35-1:05Prevention of Healthcare-Associated Infections and Sepsis in Immunocompromised HostsCatherine Liu, MD
    Fred Hutchinson Cancer Center
    1:05 - 1:35AHRQ’s Healthcare-Associated Infections (HAI) Program: Research to ImplementationMelissa Miller, MD, MS, FCCM
    Agency for Healthcare Research and Quality (AHRQ)
    1:35 - 1:50Break (Sponsored by Seres Therapeutics)
    1:50-2:20Healthcare-Acquired Infections and Sepsis: The Role of Infection Control and Environmental Management Nasia Safdar, MD, Ph.D
    University of Wisconsin School of Medicine and Public Health
    2:20-2:50The Role of Oral Biofilms and Periodontal Disease in Ventilator and Non-ventilator Associated EventsFrank Scannapieco, D.M.D., Ph.D
    University at Buffalo School of Dental Medicine
    2:50-3:20Sepsis, Healthcare-Associated Infection, and Patient Safety: Strategies for Interprofessional Prevention and Improvement
    J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, FNP-BC, IP-BC, PLNC, CFER, AS-BC, VA-BC,  HACP-IC, CMRP, LTC-CIP, CIC, DICO-C, CPPS, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, FACDONA, FAAPM, FACHDM, FNAP, FAHVAP, FACHE, FSHEA, FIDSA
    University of Louisville School of Medicine
    3:20-3:30Closing Remarks
    Cindy Hou DO, MA, MBA, FACOI, FACP, FIDSA
    Jefferson Health - East Region

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 3 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

    Financial Relationship Disclosure for All Individuals In Control of Content

    All individuals in control of content for this event, including planning committee members, presenters, and reviewers, had no relevant financial relationships to disclose.